MedTrace Logo

Healthy Lifestyles in Bipolar Disorder: Bay Area Study

NCT06555406 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-01-14

No results posted yet for this study

Summary

The goal of this clinical trial is to understand how level of adherence with time-restricted eating (TRE) predicts change in diurnal rhythms (as measured using the amplitude of diurnal peripheral clock gene expression), and how those changes predict lower mania and depressive symptoms, and downstream improvements in quality of life. The effects of diurnal amplitude of clock gene expression is expected to remain significant when controlling for change in glucose tolerance and inflammation. Participants will be enrolled who are already receiving medication treatment for bipolar disorder. Participants will complete daily measures of eating, sleep and mood for two weeks, and then will be assigned to follow TRE for eight weeks. Symptoms and Quality of Life will be measured at baseline and during and after the food plan.

Conditions

Interventions

BEHAVIORAL

Time-restricted eating for 8 weeks

limiting food intake to 10 hours per day

Sponsors & Collaborators

  • Salk Institute for Biological Studies

    collaborator OTHER

  • University College, London

    collaborator OTHER

  • Swinburne University of Technology

    collaborator OTHER

  • Deakin University

    collaborator OTHER

  • University of British Columbia

    collaborator OTHER

  • Wellcome Trust

    collaborator OTHER

  • University of California, Berkeley

    lead OTHER

Principal Investigators

  • Sheri L Johnson, PhD · University of California, Berkeley

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-22
Primary Completion
2029-02-01
Completion
2029-02-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06555406 on ClinicalTrials.gov